How has been the historical performance of Nephro Care?

Answer:The historical performance of Nephro Care shows significant growth over the years, particularly from March 2022 to March 2025. Breakdown: Nephro Care's net sales have increased dramatically from 3.42 Cr in March 2022 to 46.03 Cr in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 3.42 Cr in March 2022 to 46.03 Cr in March 2025. The company's total expenditure also grew, reaching 40.16 Cr in March 2025 from just 3.30 Cr in March 2022. Operating profit, excluding other income, peaked at 5.87 Cr in March 2025, although it was slightly lower than the previous year's 6.47 Cr. Profit before tax showed fluctuations, with a high of 6.22 Cr in March 2024 but dropping to 4.83 Cr in March 2025. Profit after tax reached 3.64 Cr in March 2025, down from 4.50 Cr in March 2024, yet still a significant improvement from the loss of 0.01 Cr in March 2022. The company's total assets surged to 68.28 Cr in March 2025 from 4.63 Cr in March 2022, while total liabilities also increased to 68.28 Cr in March 2025, indicating a balanced growth in both assets and liabilities. Cash flow from operating activities improved to 7.00 Cr in March 2025, and the closing cash and cash equivalents rose to 4.00 Cr, showcasing a positive cash position. Overall, Nephro Care's financial metrics indicate robust growth and operational scaling over the past few years.